Why Can’t You Keep Your Nipples After a Mastectomy?

Many people facing mastectomy actually can keep their nipples, and the number who do has grown dramatically over the past two decades. Nipple-sparing mastectomy (NSM) is now a well-established surgical option for a significant share of breast cancer patients and those at high genetic risk. But certain tumor characteristics, blood supply problems during surgery, and specific patient factors still make nipple preservation impossible or inadvisable in individual cases. The reasons are more varied and more interesting than most people realize.

The Short History That Explains the Default

For most of the twentieth century, removing the nipple was simply how a mastectomy worked. The radical mastectomy pioneered in the late 1800s removed not just the breast tissue and nipple but also the chest muscles and extensive lymph nodes. Over decades, surgeons gradually scaled back, moving to modified radical mastectomy and eventually to skin-sparing techniques that preserved the breast skin envelope but still removed the nipple-areola complex (NAC). The nipple was considered a liability because breast ducts converge there, and early studies found cancer cells in the tissue directly behind the nipple in a meaningful fraction of patients.¹ The assumption, for a long time, was that keeping the nipple meant leaving cancer behind.

That assumption turned out to be too broad. As imaging improved and surgeons began studying exactly which patients had tumor cells near the nipple and which did not, it became clear that many patients could safely retain the NAC. The shift toward nipple-sparing mastectomy has been one of the bigger changes in breast surgery over the last fifteen years. But the old default, removing the nipple, persists for good reason in certain clinical scenarios.

When Cancer Is Too Close

The most straightforward reason you might lose your nipple is that the tumor sits near it. The breast’s ductal system fans out from the nipple like the spokes of a wheel, and when a cancer grows along those ducts toward the center, it can reach the tissue directly behind the nipple-areola complex. Surgeons use imaging, particularly MRI, to measure the distance between the tumor and the nipple before surgery. One study found that a distance of about 10 millimeters on MRI was the most useful threshold for predicting whether cancer had already reached the nipple area, with roughly 82 percent sensitivity at that cutoff.² Tumors that are larger, multifocal (growing in more than one spot), or show extensive spread through the duct system are more likely to have crept toward the nipple even when the main mass seems far enough away.

Even when preoperative imaging looks favorable, the final call often happens in the operating room itself. After the breast tissue is removed, surgeons send a sample of the tissue directly behind the nipple for rapid frozen-section analysis. A pathologist examines it under a microscope while the patient is still on the table. If cancer cells show up, the nipple comes off right then. One study found that about 10 percent of patients who were otherwise candidates for nipple-sparing mastectomy had a positive frozen section, prompting immediate nipple removal.³ A larger study reported sensitivity of about 75 percent and specificity close to 99 percent for the frozen-section technique, meaning it catches most hidden disease and almost never gives a false alarm.⁴

Some surgeons rely on whichever imaging is available to judge the tumor-to-nipple distance rather than requiring MRI specifically, as long as the tissue behind the nipple is confirmed clear on both the rapid intraoperative check and the final pathology report that comes back days later.⁵ That two-step verification is the safety net. When both checks come back clean, nipple-sparing mastectomy has a recurrence rate at the nipple of roughly 3 to 4 percent over five years. A large study of 944 patients over a median follow-up of about seven years found a 3.5 percent five-year cumulative incidence of cancer coming back at the nipple, and those recurrences did not worsen long-term survival.⁶ An earlier series of 579 cases found that local relapses occurred at under 1 percent per year and none were located in the nipple area itself.⁷

The Blood Supply Problem

Cancer proximity is the oncological reason for nipple removal, but the other major reason is purely surgical: the nipple might not survive the operation. In a standard mastectomy, surgeons dissect the breast tissue away from the overlying skin. The nipple gets its blood supply from small vessels running through that tissue, and the dissection can damage or cut off those vessels entirely. If blood flow drops too low, the nipple dies. Partial or total necrosis of the nipple-areola complex is the most common complication of nipple-sparing mastectomy.

Imaging during surgery has helped surgeons see this in real time. One study using fluorescent dye imaging classified nipple blood flow patterns into three categories. Among nipples showing the poorest perfusion pattern, 71 percent developed serious ischemic changes, and most of those had to be removed during or after the procedure.⁸ Another study using laser-assisted imaging found that when perfusion dropped below about 13 percent of normal, nearly all nipples developed necrosis, and those below 10 percent required surgical debridement or full nipple removal.⁹

Sometimes surgeons discover inadequate blood flow only after the breast tissue has already been removed. At that point, they face a choice: keep a nipple that may turn black and die over the following days, requiring additional surgery and risking infection, or remove it on the spot for a cleaner outcome. This is why some patients who are told preoperatively that nipple-sparing is the plan wake up without their nipple. The decision was made mid-surgery because the blood supply simply was not there.

Where the Incision Goes Matters

The route a surgeon takes to reach the breast tissue affects whether the nipple survives. Incisions made around the edge of the areola, which seem intuitive because they hide the scar, actually cut through the blood vessels feeding the nipple from the surrounding skin. One study comparing approaches found that cuts around the areola led to nipple necrosis in about 38 percent of cases, compared with roughly 6 percent when the incision was placed along the side of the breast or underneath it.¹⁰ A review of the literature confirmed that incisions placed away from the nipple consistently produced the lowest rates of ischemic complications and the best cosmetic results.¹¹

Newer techniques use indocyanine green (ICG) dye injected before surgery to map exactly where the major blood vessels feeding the nipple are running, then plan the incision to avoid them. One study comparing ICG-guided incision planning to the standard blind approach found that full-thickness nipple necrosis dropped from about 13 percent to 2.5 percent when surgeons could see and avoid the main arterial inflow.¹² Another study confirmed that successfully mapping and preserving at least one vessel led to excellent flap perfusion and lower rates of wound breakdown.¹³ This technology is making nipple-sparing more successful, but it is not universally available.

Patient Factors That Raise the Risk

Certain patient characteristics make it harder for the nipple to survive surgery, even when the cancer is in a favorable location and the incision is placed well. Higher body mass index, smoking history, prior radiation therapy to the breast, and larger breast volume have all been linked to higher rates of nipple necrosis.¹⁴ Significant breast sagging (ptosis) is another factor, because in very droopy breasts the nipple sits far from the chest wall, making the blood supply more precarious and the dissection more extensive.¹⁵ Some studies have also flagged hypertension and diabetes, both of which damage small blood vessels, as potential risk factors. One series found that patients with vascular conditions had nipple necrosis rates roughly three to four times higher than those without, though the numbers in that particular study did not quite reach statistical significance.¹⁶

For patients with several of these risk factors stacking up, surgeons may recommend against nipple-sparing from the start. A nipple that looks viable immediately after surgery but slowly dies over the following week creates a much messier situation than a clean removal at the time of the mastectomy. It can delay reconstruction, introduce infection risk, and require repeat operations. For some patients, the realistic calculation is that keeping the nipple introduces more problems than it solves.

The BRCA and Prophylactic Setting

People with BRCA1 or BRCA2 mutations who choose preventive mastectomy are often excellent candidates for nipple-sparing because they typically have no active tumor. A multi-institutional study of prophylactic nipple-sparing mastectomy in BRCA carriers found no new breast cancers developed after the procedure, versus roughly 22 expected cancers had the surgery not been done.¹⁷ Another study of BRCA carriers confirmed low complication and recurrence rates, though about 5.6 percent of patients eventually needed their nipple removed after surgery for oncological concerns discovered later.¹⁸ Longer-term follow-up data continue to support the approach, though researchers emphasize that ongoing monitoring remains important.¹⁹

The prophylactic setting is where the “why can’t you keep your nipples” question often carries the most emotional weight. Someone who does not yet have cancer, choosing a major surgery to prevent it, naturally wants to preserve as much of their body as possible. The evidence increasingly supports that in most of these cases, they can.

When Chemotherapy Opens the Door

Some patients who initially are not candidates for nipple-sparing become candidates after neoadjuvant therapy, meaning chemotherapy or other systemic treatment given before surgery to shrink the tumor. One study tracked 160 patients whose tumors were initially too close to the nipple or skin for safe preservation. After completing systemic therapy, about 86 percent of them were able to undergo nipple-sparing mastectomy because the tumor shrank enough. The average tumor size dropped from about 3.1 centimeters to 1.3 centimeters, and the average distance between the cancer and the nipple increased substantially.²⁰ Another study using MRI to track the response found that when imaging showed the cancer had fully retreated from the nipple area after chemotherapy, no tumor invasion of the nipple was found on pathology in that subgroup.²¹

This is a genuinely important development. A decade ago, a tumor sitting right behind the nipple meant automatic nipple removal. Now, for certain tumor types that respond well to chemotherapy, the tumor can be pushed back far enough that the nipple is safely preserved. It does not work for everyone, and the remaining 14 percent in the study cited above either showed disease progression or had to have the nipple removed anyway. But it has expanded the pool of patients who can keep their nipples.

Keeping the Nipple Does Not Mean Keeping Sensation

Even when nipple-sparing goes well and the nipple survives with good blood flow, it probably will not feel the same. The nerves that supply sensation to the nipple and breast skin run through the tissue that is removed during mastectomy, and severing them is essentially unavoidable. One study of women who kept their nipples after mastectomy and implant reconstruction found that 57 percent reported their nipples were completely numb and another 32 percent said they had much less feeling than before surgery.²² A separate mixed-methods study found that roughly 45 percent of nipple-sparing mastectomy patients retained varying levels of nipple sensation, meaning the majority experienced some degree of numbness.²³

Some surgeons are experimenting with nerve repair at the time of reconstruction. One technique involves elongating branches of the intercostal nerves and grafting them to the breast skin and nipple area, aiming to regrow sensation over time.²⁴ This field, called neurotization, is still relatively new, and the results are far from guaranteed. But for patients who value sensation and are weighing their surgical options, it is worth asking about. The phantom sensation many mastectomy patients describe, feeling a breast or nipple that is no longer there, is a related neurological phenomenon, and the nipple is the part of the breast most commonly represented in these phantom experiences.²⁵

The Psychological and Quality-of-Life Picture

The reason patients care so much about keeping their nipple is not just cosmetic, though appearance matters. Systematic comparison of nipple-sparing versus skin-sparing mastectomy shows measurable differences in how patients feel afterward. A meta-analysis of quality-of-life data found that patients who kept their nipples scored meaningfully higher on both sexual well-being and psychosocial well-being measures.²⁶ Interestingly, overall satisfaction scores between the two groups did not differ significantly when measured with different questionnaires, suggesting that the benefit of nipple preservation is more about self-image and intimacy than about general surgical satisfaction.

What Happens When the Nipple Cannot Be Saved

If you do lose your nipple, reconstruction options have expanded considerably. Surgical techniques include various local skin flaps, each with colorful names like the skate flap, star flap, C-V flap, and arrow flap, all designed to shape a small mound of tissue into something that projects like a nipple. The skate flap is one of the most reliable for maintaining projection over time, while the star flap avoids the need for a skin graft at the donor site.²⁷ Composite grafts, which borrow tissue from elsewhere on the body like the opposite nipple or earlobe, are another option.²⁸

Medical tattooing has become increasingly sophisticated. Modern three-dimensional tattooing techniques can create a realistic-looking nipple-areola complex using shading and color alone, without any surgery at all. Patient satisfaction with these tattoos tends to be high, though the pigment does fade over time and touch-ups are common.²⁹ Tattooing is sometimes used as the final step after a surgical nipple reconstruction, adding color and detail to the reconstructed mound, and sometimes as a standalone approach for patients who prefer to avoid additional surgery.³⁰

A newer option sits between tattooing and surgery: a small silicone prosthesis implanted under the skin to create permanent nipple projection. One prosthesis includes a tiny metal frame covered in silicone, designed to maintain a natural shape and softness. In an early evaluation, 90 percent of patients were satisfied with the result, and scores for nipple satisfaction, psychosocial well-being, and sexual well-being all improved after implantation. Satisfaction with nipple projection jumped particularly sharply, from 45 percent of patients reporting satisfaction before the device to 86 percent after.³¹ These devices are still relatively new, and long-term data are limited, but they represent a different approach for patients who want lasting projection without a skin flap procedure.

The two-step technique, in which the nipple and areola are reconstructed in separate stages, is another refinement aimed at producing a more natural-looking result that holds its shape better over time compared to single-stage methods.³² The reconstruction field continues to move forward, and patients who lost their nipples years ago sometimes return to benefit from newer techniques that did not exist at the time of their mastectomy.